11β Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle
- 20 October 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 65 (6) , 800-805
Abstract
Summary: Objective No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological activity and determine its relationship with hexose‐6‐phosphate dehydrogenase (H6PDH). We also examined the muscle fibre localization of 11β HSD‐1.Design Eleven non‐diabetic community volunteers underwent muscle biopsy of vastus lateralis.Measurements (i) 11β HSD‐1 and H6PDH mRNA expression by quantitative reverse transcription polymerase chain reaction (RT‐PCR); (ii) protein localization and fibre type specificity by immunohistochemistry; and (iii) enzyme oxoreductase activity by percentage conversion of 3H cortisone to cortisol.Results 11β HSD‐1 mRNA was expressed at low levels compared to human liver. Mean ΔCT of skeletal muscle in 11 subjects was 19·57 (range 18·40–20·79) compared to ΔCT of 12·75 in human liver, which equates to an approximate 100‐fold higher level of expression. H6PDH mRNA was also detected with a mean ΔCT of 14·46 (range 13·13–16·60), approximately 35‐fold more abundant than 11β HSD‐1 in skeletal muscle. There was a significant correlation between 11β HSD‐1 and H6PDH (r = 0·67, P = 0·03). 11β HSD‐1 immunostaining was present in all muscle specimens, with similar distribution among fast and slow twitch fibres. 11β HSD‐1 oxoreductase activity was demonstrated, with mean conversion of cortisone to cortisol of 17·7% per 200 mg of muscle per 24 h (range 7·1–29·5%).Conclusions 11β HSD‐1 mRNA and protein is expressed in fresh human skeletal muscle along with readily demonstrable oxoreductase activity. 11β HSD‐1 localization is not muscle fibre type specific. High levels of skeletal muscle H6PDH should ensure that oxoreductase activity predominates in vivo.Keywords
This publication has 29 references indexed in Scilit:
- Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubesEuropean Journal of Clinical Investigation, 2005
- Skeletal Muscle Fiber Type: Influence on Contractile and Metabolic PropertiesPLOS Biology, 2004
- Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11β‐hydroxysteroid dehydrogenase type 1 as an oxoreductaseFEBS Letters, 2004
- Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adultsBritish Journal of Sports Medicine, 2003
- A Switch in Dehydrogenase to Reductase Activity of 11 -Hydroxysteroid Dehydrogenase Type 1 upon Differentiation of Human Omental Adipose Stromal CellsThe Journal of Clinical Endocrinology & Metabolism, 2002
- Regulation of Glucocorticoid Receptor and Isoforms and Type I 11 -Hydroxysteroid Dehydrogenase Expression in Human Skeletal Muscle Cells: A Key Role in the Pathogenesis of Insulin Resistance?The Journal of Clinical Endocrinology & Metabolism, 2001
- Light and Electron Microscopy Localization of the 11 -Hydroxysteroid Dehydrogenase Type I Enzyme in the RatEndocrinology, 2001
- Defects of Insulin Action and Skeletal Muscle Glucose Metabolism in Growth Hormone-Deficient Adults Persist after 24 Months of Recombinant Human Growth Hormone TherapyThe Journal of Clinical Endocrinology & Metabolism, 1998
- Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzymeMolecular and Cellular Endocrinology, 1994
- Actomyosin ATPase. II. Fiber typing by histochemical ATPase reactionMuscle & Nerve, 1980